TrialThe Journal of antimicrobial chemotherapy2025

Cardiac safety of bedaquiline, delamanid and moxifloxacin co-administered with or without varying doses of sutezolid or delpazolid for the treatment of drug-susceptible TB.

Simon E Koele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.